InvestorsHub Logo
Followers 139
Posts 23261
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 01/12/2022 6:34:07 PM

Wednesday, January 12, 2022 6:34:07 PM

Post# of 1125
A MUST READ

NRx Pharmaceuticals Files Counterclaim Against its Former Collaboration Partner, Relief Therapeutics
JANUARY 12, 2022 5:48PM EST

- Documents NRx's development of a potentially lifesaving drug for treatment of Covid-19 despite Relief's breach and repudiation of the collaboration agreement

- Details Relief's false claims of worldwide rights to Aviptadil and to ongoing phase 3 research, misleading NRx and the public

- Identifies Raghuram Selvaraju's history of collaborating with Relief principals and associates on prior matters that have led to sanctions, fines, and incarceration

- Documents Relief's attempt to extort NRx into using Relief's ineffective and potentially harmful formulation of Aviptadil

- Debunks the libelous claim that NRx caused harm to patients in Europe by withholding patient data

https://ir.nrxpharma.com/news-events/press-releases/detail/111/nrx-pharmaceuticals-files-counterclaim-against-its-former

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News